Chapter title |
Acral Lentiginous Melanoma
|
---|---|
Chapter number | 14 |
Book title |
Melanoma
|
Published in |
Cancer treatment and research, January 2016
|
DOI | 10.1007/978-3-319-22539-5_14 |
Pubmed ID | |
Book ISBNs |
978-3-31-922538-8, 978-3-31-922539-5
|
Authors |
James S. Goydos, Steven L. Shoen, Goydos, James S., Shoen, Steven L. |
Abstract |
Acral lentiginous melanoma (ALM) is a rare subtype of melanoma mainly arising on the palms, soles, and nail beds. ALM is the most common subtype of melanoma found in patients of Asian or African descent and tends to more advanced at presentation due to delays in diagnosis. Surgical treatment is difficult owing to the complexity and functional importance of the hands and feet and reconstruction after resection is usually needed. The prognosis for patients with ALM depends on stage of disease and tends to be worse than with other subtypes of melanoma. Newer treatment modalities such as immunotherapies and targeted agents are being tested in patients with advanced ALM with some promising preliminary results. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 125 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 13 | 10% |
Student > Bachelor | 13 | 10% |
Student > Master | 12 | 10% |
Student > Doctoral Student | 10 | 8% |
Student > Ph. D. Student | 10 | 8% |
Other | 25 | 20% |
Unknown | 42 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 41% |
Biochemistry, Genetics and Molecular Biology | 12 | 10% |
Nursing and Health Professions | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
Unspecified | 2 | 2% |
Other | 7 | 6% |
Unknown | 45 | 36% |